- Home
- BDX vs TRI Comparison
BDX vs TRI Comparison
Compare BDX & TRI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BDX
- TRI
- Stock Information
- Founded
- BDX 1897
- TRI 1851
- Country
- BDX United States
- TRI Canada
- Employees
- BDX N/A
- TRI N/A
- Industry
- BDX Medical/Dental Instruments
- TRI
- Sector
- BDX Health Care
- TRI
- Exchange
- BDX Nasdaq
- TRI Nasdaq
- Market Cap
- BDX 66.1B
- TRI 69.8B
- IPO Year
- BDX 1962
- TRI N/A
- Fundamental
- Price
- BDX $240.29
- TRI $162.38
- Analyst Decision
- BDX Strong Buy
- TRI Buy
- Analyst Count
- BDX 6
- TRI 8
- Target Price
- BDX $283.50
- TRI $178.38
- AVG Volume (30 Days)
- BDX 1.9M
- TRI 232.6K
- Earning Date
- BDX 02-06-2025
- TRI 02-06-2025
- Dividend Yield
- BDX 1.73%
- TRI 1.33%
- EPS Growth
- BDX 18.61
- TRI 5.99
- EPS
- BDX 5.86
- TRI 5.07
- Revenue
- BDX $20,178,000,000.00
- TRI $7,164,000,000.00
- Revenue This Year
- BDX $10.12
- TRI $8.01
- Revenue Next Year
- BDX $5.02
- TRI $3.88
- P/E Ratio
- BDX $41.01
- TRI $32.02
- Revenue Growth
- BDX 4.16
- TRI 6.23
- 52 Week Low
- BDX $218.75
- TRI $148.16
- 52 Week High
- BDX $248.42
- TRI $176.03
- Technical
- Relative Strength Index (RSI)
- BDX 69.00
- TRI 53.71
- Support Level
- BDX $227.66
- TRI $151.60
- Resistance Level
- BDX $238.00
- TRI $162.78
- Average True Range (ATR)
- BDX 4.67
- TRI 2.36
- MACD
- BDX 0.97
- TRI 0.23
- Stochastic Oscillator
- BDX 94.06
- TRI 95.15
About BDX Becton Dickinson and Company
Becton, Dickinson is the world's largest manufacturer and distributor of medical surgical products, such as needles, syringes, and sharps-disposal units. The company also manufactures prefilled devices, diagnostic instruments and reagents, as well as flow cytometry and cell-imaging systems. BD Medical is nearly half of the total business, while BD Life Sciences (27% of 2024 revenue) and BD Interventional (24%) account for the remainder. International revenue accounts for 43% of the company's business.
About TRI Thomson Reuters Corp
Thomson Reuters is the result of the $17.6 billion megamerger of Canada's Thomson and the United Kingdom's Reuters Group in 2008. In 2021, Thomson Reuters completed the sale of Refinitiv to LSE Group. Thomson Reuters' three largest segments are its legal professionals, Tax and accounting, and corporates segments. Legal professionals is about 42% of the firm's revenue and 47% of the firm's adjusted EBITDA. Tax and accounting makes up about 20%-25% of the firm's revenue and EBITDA. Corporates, which consists of legal professionals and tax and accounting products sold to corporations, also makes up about 20%-25% of the firm's revenue and EBITDA. Thomson Reuters' smaller segments include its Reuters news business and global print business.